105 related articles for article (PubMed ID: 18261991)
61. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
[TBL] [Abstract][Full Text] [Related]
62. Molecular mechanisms of regulation of sphingosine kinase 1.
Pulkoski-Gross MJ; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Nov; 1863(11):1413-1422. PubMed ID: 30591148
[TBL] [Abstract][Full Text] [Related]
63. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
64. The emerging role of FTY720 (Fingolimod) in cancer treatment.
White C; Alshaker H; Cooper C; Winkler M; Pchejetski D
Oncotarget; 2016 Apr; 7(17):23106-27. PubMed ID: 27036015
[TBL] [Abstract][Full Text] [Related]
65. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-γ that regulates neoangiogenesis.
Parham KA; Zebol JR; Tooley KL; Sun WY; Moldenhauer LM; Cockshell MP; Gliddon BL; Moretti PA; Tigyi G; Pitson SM; Bonder CS
FASEB J; 2015 Sep; 29(9):3638-53. PubMed ID: 25985799
[TBL] [Abstract][Full Text] [Related]
66. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
Tabeling C; Yu H; Wang L; Ranke H; Goldenberg NM; Zabini D; Noe E; Krauszman A; Gutbier B; Yin J; Schaefer M; Arenz C; Hocke AC; Suttorp N; Proia RL; Witzenrath M; Kuebler WM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1614-23. PubMed ID: 25829545
[TBL] [Abstract][Full Text] [Related]
67. Fingolimod for the treatment of neurological diseases-state of play and future perspectives.
Brunkhorst R; Vutukuri R; Pfeilschifter W
Front Cell Neurosci; 2014; 8():283. PubMed ID: 25309325
[TBL] [Abstract][Full Text] [Related]
68. The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertension.
Chen J; Tang H; Sysol JR; Moreno-Vinasco L; Shioura KM; Chen T; Gorshkova I; Wang L; Huang LS; Usatyuk PV; Sammani S; Zhou G; Raj JU; Garcia JG; Berdyshev E; Yuan JX; Natarajan V; Machado RF
Am J Respir Crit Care Med; 2014 Nov; 190(9):1032-43. PubMed ID: 25180446
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.
Venkata JK; An N; Stuart R; Costa LJ; Cai H; Coker W; Song JH; Gibbs K; Matson T; Garrett-Mayer E; Wan Z; Ogretmen B; Smith C; Kang Y
Blood; 2014 Sep; 124(12):1915-25. PubMed ID: 25122609
[TBL] [Abstract][Full Text] [Related]
70. Sphingosine-1-Phosphate as a Regulator of Hypoxia-Induced Factor-1α in Thyroid Follicular Carcinoma Cells.
Kalhori V; Kemppainen K; Asghar MY; Bergelin N; Jaakkola P; Törnquist K
PLoS One; 2013; 8(6):e66189. PubMed ID: 23824493
[TBL] [Abstract][Full Text] [Related]
71. Sphingosine kinase 1 in cancer.
Heffernan-Stroud LA; Obeid LM
Adv Cancer Res; 2013; 117():201-35. PubMed ID: 23290781
[TBL] [Abstract][Full Text] [Related]
72. Hypoxic preconditioning induces stroke tolerance in mice via a cascading HIF, sphingosine kinase, and CCL2 signaling pathway.
Wacker BK; Perfater JL; Gidday JM
J Neurochem; 2012 Dec; 123(6):954-62. PubMed ID: 23043544
[TBL] [Abstract][Full Text] [Related]
73. Interleukin-11 protects against renal ischemia and reperfusion injury.
Lee HT; Park SW; Kim M; Ham A; Anderson LJ; Brown KM; D'Agati VD; Cox GN
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1216-24. PubMed ID: 22859402
[TBL] [Abstract][Full Text] [Related]
74. Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia.
Park SW; Kim M; Kim JY; Brown KM; Haase VH; D'Agati VD; Lee HT
Kidney Int; 2012 Oct; 82(8):878-91. PubMed ID: 22695326
[TBL] [Abstract][Full Text] [Related]
75. Induction of gastrin expression in gastrointestinal cells by hypoxia or cobalt is independent of hypoxia-inducible factor (HIF).
Xiao L; Kovac S; Chang M; Shulkes A; Baldwin GS; Patel O
Endocrinology; 2012 Jul; 153(7):3006-16. PubMed ID: 22593272
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of sphingosine kinase 1 suppresses proliferation of glioma cells under hypoxia by attenuating activity of extracellular signal-regulated kinase.
Zhang H; Li W; Sun S; Yu S; Zhang M; Zou F
Cell Prolif; 2012 Apr; 45(2):167-75. PubMed ID: 22288844
[TBL] [Abstract][Full Text] [Related]
77. Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury.
Mayeux PR; MacMillan-Crow LA
Pharmacol Ther; 2012 May; 134(2):139-55. PubMed ID: 22274552
[TBL] [Abstract][Full Text] [Related]
78. Thiazolidinedione-dependent activation of sphingosine kinase 1 causes an anti-fibrotic effect in renal mesangial cells.
Koch A; Völzke A; Wünsche C; Meyer zu Heringdorf D; Huwiler A; Pfeilschifter J
Br J Pharmacol; 2012 Jun; 166(3):1018-32. PubMed ID: 22221312
[TBL] [Abstract][Full Text] [Related]
79. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.
Sirica AE
Nat Rev Gastroenterol Hepatol; 2011 Nov; 9(1):44-54. PubMed ID: 22143274
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury.
Park SW; Kim M; Brown KM; D'Agati VD; Lee HT
J Am Soc Nephrol; 2012 Feb; 23(2):266-80. PubMed ID: 22095950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
